# Medical Aesthetics
Latest news and articles about Medical Aesthetics
Total: 4 articles found
The Deflation of China’s ‘Beauty Premium’: Imeik and the Cooling of the Aesthetic Economy
Imeik Technology, once a titan of China's medical aesthetics market, has seen its valuation collapse by 80% amid its first-ever decline in both revenue and profit. The company's struggles highlight a broader transition in Chinese consumption as 'involution' and price sensitivity replace the high-margin growth of the previous decade.
China’s Under-the-Counter Injectables: The Dangerous Proliferation of DIY Medical Aesthetics
An investigation has uncovered that major Chinese e-commerce platforms are illegally selling Class III medical injectables directly to consumers. Driven by a trend of 'consumer downgrading,' this grey market bypasses professional oversight, leading to severe medical risks and exposing significant regulatory gaps in the platform economy.
Haier Refutes ‘Vampire’ Therapy Claims as Fringe Wellness Hits Corporate China
Haier Group has issued a formal denial regarding any involvement in controversial 'blood-replacement' therapies or partnerships with entrepreneur Yu Wenhong. The conglomerate is pursuing legal action to protect its healthcare brand, Yingkang Life, from reputational damage caused by fringe medical claims.
Blood and Beauty: Boya Bio’s Aesthetics Misadventure Triggers 70% Profit Plunge
Boya Bio-Pharmaceutical saw its 2025 net profits crash by over 70% due to a massive impairment in its acquired medical aesthetics business and regulatory headwinds in the blood products market. The crisis is compounded by the sudden resignation of its CEO after only nine months, signaling deeper governance and strategic integration issues.